Related Experiment Videos
Malignant lymphoma in a renal transplant recipient treated with antithymocyte globulin
Transplantation
|March 1, 1983
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Predicting High-Dose-Rate Brachytherapy Boost Benefit Using Hypoxia and Angiogenesis Gene Expression in Localised Prostate Cancer.
Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Does Overall Treatment Time Impact Toxicity and Clinical Outcomes After Magnetic Resonance Imaging-Guided Stereotactic Body Radiotherapy to the Prostate? An evaluation of the Multi-OutcoMe EvaluatioN of radiation Therapy Using the MR-Linac Repository.
Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Reirradiation Options for Previously Irradiated Prostate Cancer: Is It Feasible to Randomise Between Treatment With Stereotactic Body Radiotherapy (SBRT) Versus High-Dose-Rate Brachytherapy?
Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Unravelling Salvage Re-irradiation for Locally Recurrent Prostate Cancer: Challenges and Complexities.
Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Hepatitis B virus reactivation risk in haploidentical versus matched donor transplantation: Impact of universal prophylaxis.
Hematology, transfusion and cell therapy·2026
Correlations between autograft cellular components and post-transplant outcome in patients with systemic non-Hodgkin lymphoma mobilized with on-demand plerixafor: A prospective multicenter GOA study.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Porcine kidney xenotransplantation as a bridge to allotransplantation: a first-in-human study.
Lancet (London, England)·2026